UltraClean DEPC Treated MOPS Buffer, 1X

Product#: DCP-MOPSDEPC1X
$88.00
DCP-MOPSDEPC1X
Availability:
Ships in 24 hours

FluxMPS™ Buffer
ISO 13485 Certified Manufacturing

FluxMPS™ UltraClean DEPC Treated MOPS Buffer, 1X

An MPS-grade, sterile MOPS electrophoresis buffer built for nuclease-sensitive RNA and DNA workflows. Treated with diethyl pyrocarbonate (DEPC) and ultra-filtered through a 0.1 µm membrane twice and a 0.04 µm membrane twice, it delivers precise pH 7.0 buffering with a defined 20 mM MOPS / 5 mM sodium acetate / 1 mM EDTA formulation for microchannel-safe, nuclease-free workflows.

  • Sterile, ultrapure buffer filtered through a 0.1 µm membrane twice and a 0.04 µm membrane twice
  • DEPC-treated and nuclease-free, inactivating RNases and DNases to protect RNA and DNA integrity
  • Precise pH 7.0 with defined 20 mM MOPS, 5 mM sodium acetate, and 1 mM EDTA composition
  • Manufactured with molecular biology-grade reagents in ISO 13485-certified, CE-approved facilities
  • Colorless, clear, sterile solution suited for RNA electrophoresis, Northern blotting, and sample preparation
  • Available in 500 mL and 1000 mL sizes, with custom pH, concentration, and additive formulations on request
SKU: DCP-MOPSDEPC1X UNSPSC 12352204 RNA Works Buffer
UltraClean DEPC Treated MOPS Buffer, 1X — Sterile, DEPC-Treated Concentrate
  • pH7.0
  • FormulationMOPS, Sodium Acetate, EDTA
  • MOPS Concentration20 mM
  • EDTA Concentration1 mM
  • Nuclease StatusRNase/DNase-free (DEPC-treated)
  • Filtration0.1 µm x2 + 0.04 µm x2
  • SterilitySterile
  • AppearanceColorless, clear solution
  • Storage4 °C
  • Shelf Life12 months
ISO 13485:2016 USP <85> <785> <788> RUO
Why FluxMPS™

Engineered where standard nuclease-sensitive buffers fail

Conventional single-pass 0.22 µm-filtered buffers can carry residual particulates, trace nucleases, and inconsistent pH that compromise RNA integrity, microchannel performance, and assay background. UltraClean DEPC Treated MOPS Buffer addresses each failure mode with defined chemistry and multi-stage purification.

filter_alt

Microchannel-safe purity

Sequential 0.1 µm and 0.04 µm membrane filtration, each applied twice, reduces particulate load beyond a single conventional pass.

target

Precise, stable pH

Defined 20 mM MOPS, 5 mM sodium acetate, and 1 mM EDTA formulation is manufactured to pH 7.0 for reproducible RNA electrophoresis performance.

water_drop

Ultrapure-grade water

Formulated with DEPC-treated, nuclease-free water manufactured under Ultrapure Type 1 water (18.2 MΩ·cm) standards, per USP <85>.

visibility

Low background for RNA work

Nuclease-free, DEPC-treated chemistry supports Northern blotting, RNA electrophoresis, and other nuclease-sensitive imaging and detection workflows.

science

Defined, traceable composition

Every component — MOPS, sodium acetate, EDTA, and DEPC-treated water — is manufactured to a fixed, documented concentration.

tune

Customization on demand

Alternate concentrations, additional chemicals, compounds, proteins, supplements, and pH values are available on inquiry.

Purity Architecture

Quadruple-stage filtration system

DCP-MOPSDEPC1X is sterile-filtered through a 0.1 µm membrane twice and a 0.04 µm membrane twice, a four-pass architecture designed to remove progressively finer particulates and protect nuclease-sensitive RNA and DNA workflows.

  1. 1

    0.1 µm Pre-filtration I

    Removes large particulates and aggregates, extending the service life of downstream filtration stages.

  2. 2

    0.04 µm Pre-filtration II

    Retains fine particulates and bioburden; mycoplasma species can be as small as approximately 0.2 micron, well above this membrane's rating.

  3. 3

    0.1 µm Sterile-filtration I

    A second 0.1 µm pass provides redundancy ahead of final polishing.

  4. 4

    0.04 µm Sterile-filtration II — Final Polish

    A second 0.04 µm pass delivers the final polish under an ISO Class 5 (Class 100) aseptic fill, preventing mycoplasma contamination.

Performance vs. conventional buffer

Sequential 0.1 µm and 0.04 µm membrane filtration, each applied twice, removes finer particulates than a single conventional 0.22 µm pass, supporting nuclease-sensitive RNA and DNA workflows.

0.04 µm
Final filtration stage
4
Total filtration stages
All DiagnoCine Precision Sterile buffers are filter-sterilized with 0.1 µm filtration and 0.04 µm filtration twice, preventing mycoplasma contamination.
DCP-MOPSDEPC1X UltraClean DEPC Treated MOPS Buffer quadruple-stage 0.1 micron and 0.04 micron filtration diagram for organ-on-a-chip and microfluidic RNA workflows, Diagnocine
Figure 1. Quadruple-stage filtration: 0.1 µm membrane (twice) and 0.04 µm membrane (twice).
© Diagnocine® — DCP-MOPSDEPC1X
Applications

Where UltraClean DEPC Treated MOPS Buffer is used

Formulated for sensitive molecular biology applications, especially those involving RNA, and suitable for a range of nuclease-free workflows.

Automated Bioreactors & Robotics

Next-Generation System Uptime

For automated perfusion and robotics platforms, an optional 0.01 µm (10 nm) ultra-filtered variant of this buffer is available on request.

  • Total Particulate Exclusion for sensitive automated fluid paths
  • Valve & Sensor Protection in long-run robotic liquid handling
  • Extended Perfusion Stability for automated bioreactor workflows

Inquiry Required: Contact support@diagnocine.com to request the 0.01 µm ultra-filtered grade.

Microfluidics

Micro Physiological System (MPS) & Chip

Nuclease-free, ultra-filtered formulation compatible with RNA-sensitive microfluidic and chip-based workflows.

OoCToCBoCLoCMPS
Sample Preparation

RNA & DNA Sample Preparation

Used in the preparation and handling of RNA and DNA samples to prevent nuclease-mediated degradation.

LysisDilutionReconstitutionRinse
Stem Cell Biology

iPSC-Derived Model Handling

Usable as a buffering agent in cell culture media for mammalian cell models, including stem cell-derived systems.

iPSC-NeuronsiPSC-CMiPSC-Hep
Vascular Biology

Endothelial & Primary Cell Perfusion

Suitable as a buffering agent in cell culture media for bacteria, yeast, and mammalian cells, including primary cell perfusion protocols.

HUVECsHAECsPrimary hepatocytes
Immunoassays

RNA Electrophoresis & Blotting

Ideal for agarose gel electrophoresis of RNA, such as in Northern blot analysis, due to its nuclease-free, RNA-integrity-preserving formulation.

ELISAWestern blotIHCIF
Live-Cell Imaging

Protein Purification & Optical Sensing

Suitable for use as a buffer in protein purification protocols and chromatography where nuclease-free conditions are required.

ConfocalBiosensorsTEER
Technical Specifications

Product specifications

All values below are specific to DCP-MOPSDEPC1X as manufactured and released.

Physical & Chemical Parameters
Parameter Specification
Formulation / Composition MOPS, Sodium Acetate, EDTA in DEPC-treated, nuclease-free water
Appearance Colorless, clear solution
pH USP <791> 7.0
MOPS Concentration 20 mM
Sodium Acetate Concentration 5 mM
EDTA Concentration 1 mM
Sterility & Purity Parameters
Parameter Specification
Sterility Sterile, sterile-filtered
Nuclease Status RNase/DNase-free (DEPC-treated)
Filtration System 0.1 µm membrane (twice) and 0.04 µm membrane (twice)
Water Quality DEPC-treated, nuclease-free water
Manufacturing Standard ISO 13485 ISO 13485-certified, CE-approved
Fill Environment ISO Class 5 (Class 100)
Storage & Handling
Parameter Specification
Storage Temperature 4 °C
Shelf Life 12 months
Expiry Use before expiry date on product label
Raw Materials & Regulatory Traceability
Parameter Specification
Raw Material Grade Molecular biology-grade reagents
Manufacturing Site DiagnoCine Precision, Totowa, New Jersey, USA
Manufacturing QMS ISO 13485-certified
Regulatory Alignment CE-approved
Production Method DEPC treatment with sterile 0.1 µm / 0.04 µm filtration (twice each)
Intended Use Research Use Only (RUO)
Formulation

Full composition

Every component of DCP-MOPSDEPC1X is manufactured to a defined concentration and released per lot.

Component CAS Number Concentration
MOPS 1132-61-2 20 mM
Sodium Acetate 127-09-3 5 mM
EDTA 60-00-4 1 mM
Water (DEPC-treated, nuclease-free) 7732-18-5 To volume
Please inquire if other concentrations, additions of chemicals, compounds, proteins, supplements, different pH, or other modifications are needed — contact support@diagnocine.com.
Quality Assurance

Manufacturing & compliance

DCP-MOPSDEPC1X is manufactured under ISO 13485-certified and CE-approved facilities, with final packaging, quality assurance, and testing performed at the DiagnoCine R&D and Quality Testing Center.

verified

ISO 13485:2016 QMS

Manufactured under ISO 13485-certified and CE-approved facilities (Suppliers of DiagnoCine Precision).

water_drop

Ultrapure Water

Formulated with DEPC-treated, nuclease-free water.

biotech

ISO Class 5 Fill & Finish

Filter-sterilized with 0.1 µm and 0.04 µm filtration twice under an ISO Class 5 (Class 100) fill.

assignment

Micro-Batch Precision

All specific customization requests and assembly are accomplished at DiagnoCine Precision in Totowa, New Jersey, USA.

Nuclease-Free Verification

DEPC treatment inactivates RNases and DNases, ensuring suitability for RNA work and other nuclease-sensitive applications.

Mycoplasma Prevention

0.1 µm and 0.04 µm filtration applied twice prevents mycoplasma contamination.

Appearance & pH Release

Released as a colorless, clear solution at pH 7.0.

Documentation / CoA

Certificate of Analysis available on request.

Request a Certificate of Analysis for this lot at support@diagnocine.com.
Product Comparison

How DCP-MOPSDEPC1X compares

A side-by-side view of DCP-MOPSDEPC1X against conventional single-pass filtered MOPS buffers.

Parameter DCP-MOPSDEPC1X (FluxMPS™) Conventional (0.22 µm filtered) buffer Standard alternative (0.22 µm filtered) buffer
Nuclease Treatment (DEPC) check_circle cancel cancel
Final Filtration Pore Size 0.04 µm 0.22 µm 0.22 µm
Number of Filtration Stages 4 1 1
Water Quality DEPC-treated, nuclease-free Standard purified water Standard purified water
Manufacturing QMS check_circle ISO 13485 cancel cancel
Microfluidic Channel Compatibility check_circle cancel cancel
Custom Formulation Available check_circle cancel cancel
FAQ

Frequently asked questions

Answers to common questions about DCP-MOPSDEPC1X.

Yes. Its nuclease-free, ultra-filtered formulation is compatible with microfluidic, organ-on-a-chip, and other RNA-sensitive chip-based workflows.
DCP-MOPSDEPC1X is filtered through a 0.1 µm membrane twice and a 0.04 µm membrane twice, a four-pass architecture that retains progressively finer particulates and mycoplasma-sized contaminants (mycoplasma species can be as small as approximately 0.2 micron) beyond what a single 0.22 µm pass captures.
The buffer is manufactured to pH 7.0 with 20 mM MOPS, 5 mM sodium acetate, and 1 mM EDTA. Alternate concentrations, additional chemicals, compounds, proteins, supplements, different pH, and other modifications are available on inquiry.
pH is specified at 7.0 for this formulation. The buffer should be stored at 4 °C, with a 12-month shelf life when used before the expiry date printed on the product label.
Yes. Please inquire if other concentrations, additions of chemicals, compounds, proteins, supplements, different pH, or other modifications are needed.
A specific endotoxin value is not published for this formulation. The buffer is manufactured sterile, filtered through a 0.1 µm membrane twice and a 0.04 µm membrane twice, within an ISO 13485-certified, CE-approved facility. Contact support for Certificate of Analysis details.
Yes, a Certificate of Analysis is available on request at support@diagnocine.com.
Scientific References

Supporting literature

Curated literature relevant to DEPC treatment, MOPS buffering, RNA electrophoresis, and microfluidic buffer use.

  1. Fedorcsak, I. & Ehrenberg, L. Effects of diethyl pyrocarbonate and methyl methanesulfonate on nucleic acids and nucleases. Acta Chem Scand. doi:10.3891/acta.chem.scand.20-0107
  2. Lehrach, H. et al. RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry. doi:10.1021/bi00591a005
  3. Good, N. E. et al. Hydrogen ion buffers for biological research. Biochemistry. doi:10.1021/bi00866a011
  4. Huang, Y. et al. Engineering microfluidic organ-on-a-chip systems for drug screening and disease modeling applications. Micromachines. doi:10.3390/mi11070599
  5. Bhatia, S. N. & Ingber, D. E. Microfluidic organs-on-chips. Nat Biotechnol. doi:10.1038/nbt.2989
  6. Masters, J. R. Mycoplasma infection of cell cultures. Nat Rev Mol Cell Biol. doi:10.1038/nrm757
  7. Farrell, R. E. RNA Methodologies: A Laboratory Guide for Isolation and Characterization. Academic Press. doi:10.1016/C2009-0-64086-X
  8. Sackmann, E. K. et al. The present and future role of microfluidics in biomedical research. Nature. doi:10.1038/nature13118

Satisfaction
Quality Rating
Value Rating
Style Rating
X